RESTRUX
Live / Registered — Registered (as of 04 Jan 2022)
What this means for you
Registered since 04 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90309240
- Registration number
- 6609723
- Mark type
- Stylized text
- Filed
- 10 Nov 2020
- Published for opposition
- 25 May 2021
- Registered
- 04 Jan 2022
Goods and services
- Class 005 — Pharmaceuticals: Human cadaveric bone tissue intended for subsequent implantation in a patient; human cadaveric bone tissue, cleaned and processed to remove cellular elements, intended for subsequent implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human allograft tissue used to stimulate new bone formation in spine, orthopedic, and trauma surgical applications; all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
Owner
- Corelink, LLC, St. Louis, MO, US
- Corelink, LLC, St. Louis, MO, US
- Corelink, LLC, St. Louis, MO, US
Prosecution history
- 10 Feb 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 10 Feb 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 04 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 02 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Nov 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Oct 2021 — USE AMENDMENT FILED
- 05 Nov 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Oct 2021 — TEAS STATEMENT OF USE RECEIVED
- 20 Jul 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 May 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 May 2021 — PUBLISHED FOR OPPOSITION
- 05 May 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Apr 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Apr 2021 — EXAMINER'S AMENDMENT ENTERED